Page last updated: 2024-10-31

deoxyepinephrine and Body Weight

deoxyepinephrine has been researched along with Body Weight in 6 studies

Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
"50 patients with congestive heart failure underwent monitored long-term treatment aimed at evaluating the effect of ibopamine (SB-7505), the 3,4-diisobutyryl ester of N-methyldopamine, on their condition."7.67Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure. ( Avanzini, Z; Bellogini, GC; Brusoni, B; Ciampani, N; Dei Cas, L; Gazzola, U; Maggi, GC; Mangiavacchi, M; Metra, M; Pinca, L, 1986)
"50 patients with congestive heart failure underwent monitored long-term treatment aimed at evaluating the effect of ibopamine (SB-7505), the 3,4-diisobutyryl ester of N-methyldopamine, on their condition."3.67Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure. ( Avanzini, Z; Bellogini, GC; Brusoni, B; Ciampani, N; Dei Cas, L; Gazzola, U; Maggi, GC; Mangiavacchi, M; Metra, M; Pinca, L, 1986)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Decara, JM1
Pavón, FJ1
Suárez, J1
Romero-Cuevas, M1
Baixeras, E1
Vázquez, M1
Rivera, P1
Gavito, AL1
Almeida, B1
Joglar, J1
de la Torre, R1
Rodríguez de Fonseca, F1
Serrano, A1
Melloni, GF1
Minoja, GM1
Scorazzati, G1
Bauer, R1
Brusoni, B2
Ghirardi, P1
Stefoni, S1
Colì, L1
Mosconi, G1
Prandini, R1
Avanzini, Z1
Bellogini, GC1
Ciampani, N1
Dei Cas, L1
Gazzola, U1
Maggi, GC1
Mangiavacchi, M1
Metra, M1
Pinca, L1
Ferrari, V1
Sher, D1
Marchetti, G1

Trials

2 trials available for deoxyepinephrine and Body Weight

ArticleYear
Renal effect of SB 7505: a double-blind study.
    European journal of clinical pharmacology, 1981, Volume: 19, Issue:3

    Topics: Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Deoxyepinephrine; Dopamine; Double-Blin

1981
Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure. SK & F Ibopamine Working Group.
    Cardiovascular drugs and therapy, 1989, Volume: 3, Issue:6

    Topics: Amiloride; Body Weight; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Drug Combinations

1989

Other Studies

4 other studies available for deoxyepinephrine and Body Weight

ArticleYear
Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.
    Disease models & mechanisms, 2015, Oct-01, Volume: 8, Issue:10

    Topics: Adiposity; Animals; Body Weight; Deoxyepinephrine; Ether-A-Go-Go Potassium Channels; Feeding Behavio

2015
Ibopamine (SB 7505) in normal subjects and in chronic renal failure: a preliminary report.
    British journal of clinical pharmacology, 1981, Volume: 11, Issue:1

    Topics: Adult; Aged; Body Weight; Creatinine; Deoxyepinephrine; Dopamine; Female; Glomerular Filtration Rate

1981
Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:2A

    Topics: Adult; Aged; Body Weight; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dopamine; Female; H

1986
A survey of 311 patients receiving ibopamine mainly during hospital treatment for severe congestive heart failure.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:2A

    Topics: Age Factors; Aged; Blood Pressure; Body Weight; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Fema

1986